Let’s get the word out about meningitis B

We send our kids out into the world, full of hope. And we don't want something like meningitis B getting in their way.

Not an actual group.
For illustrative purposes only.

BEXSERO is an FDA-approved vaccine to prevent invasive disease caused by Neisseria meningitidis serogroup B. BEXSERO is approved for use in individuals aged 10 through 25 years.

Approval of BEXSERO is based on demonstration of immune response against three serogroup B strains representative of prevalent strains in the United States. The effectiveness of BEXSERO against diverse serogroup B strains has not been confirmed.

BEXSERO may not protect all individuals.

BEXSERO is the ONLY
meningitis B vaccine
that can
be completed in as fast as
1 month with just 2 doses

Help protect your teen against meningitis B.

Talk to your healthcare professional about vaccination with BEXSERO.

FIND OUT WHERE TO GET BEXSERO

More than 80% of 17-year-olds in the US had not received any meningitis B vaccines as of 2018

The meningitis vaccine people may have received when they were younger covered meningitis ACWY, not meningitis B. That's because a meningitis B vaccine wasn't available until 2014.

BEXSERO is a vaccine approved to help prevent meningitis B.

Although meningitis B is uncommon,
it's not a chance you want to take

Increased
rates.

16- to 23-year-olds have increased rates of meningitis B

Uncommon but can be fatal.

About 10-15 out of 100 people infected with meningitis B will die, sometimes within 24 hours

Sudden & unpredictable.

Meningitis B strikes quickly - usually without warning

MORE ABOUT MENINGITIS B

Need reminders for the second dose of BEXSERO?

It’s important to get both doses of BEXSERO. Sign up for GSK’s 2nd Dose Reminder Service for Meningitis B.You’ll get text message reminders to help you remember to schedule your next appointment and get the 2nd dose.

GET 2nd DOSE REMINDERS

Important Safety Information
About BEXSERO

  • Anyone who is allergic to the ingredients of BEXSERO or who had a severe allergic reaction after a previous dose should not receive BEXSERO
  • The tip caps of the prefilled syringes contain natural rubber latex, which may cause allergic reactions

Important Safety Information About BEXSEROImportant Safety Information
About BEXSERO

  • Anyone who is allergic to the ingredients of BEXSERO or who had a severe allergic reaction after a previous dose should not receive BEXSERO
  • The tip caps of the prefilled syringes contain natural rubber latex, which may cause allergic reactions
  • Tell your healthcare provider if you are pregnant, plan to become pregnant, or are breastfeeding
  • Fainting can happen after getting BEXSERO. Sometimes people who faint can fall and hurt themselves. For this reason, your healthcare provider may ask you to sit or lie down for 15 minutes after receiving BEXSERO
  • The most common side effects are pain, redness or hardness at the injection site; muscle pain; fatigue; headache; nausea; and joint pain
  • Some individuals with weakened immune systems may have reduced immune responses to BEXSERO
  • Individuals with certain complement deficiencies and individuals receiving treatment that inhibits terminal complement activation (for example, eculizumab) are at increased risk for invasive disease caused by Neisseria meningitidis group B even after being vaccinated with BEXSERO
  • Vaccination with BEXSERO may not result in protection in all vaccine recipients
  • Ask your healthcare provider about the risks and benefits of BEXSERO. Only a healthcare provider can decide if BEXSERO is right for you or your child